GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies. Scheen AJ. Diabetes Metab 2025;51:101681.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Scheen AJ. GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies. Diabetes Metab 2025;51:101681.
PMID: 40571191